Progression of Cognitive Deficit in Older People with Mild Cognitive Impairment Treated with Cerebrolysin
Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=51247#.VGAbCGfHRK0
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=51247#.VGAbCGfHRK0
Author(s)
1Laboratory of Neurochemistry, Moscow, Russia.
2Department of Alzheimer’s Disease and Related Disorders, Moscow, Russia.
3Department of Bioengineering and Medical Equipment and Systems, Moscow State Technical University, Moscow, Russia.
4Laboratory of Biostatistics and Evidence Based Medicine, Mental Health Research Center of Russian Academy of Medical Sciences, Moscow, Russia.
5Institute of Neurocience, Newcastle University Institute for Ageing, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, UK.
2Department of Alzheimer’s Disease and Related Disorders, Moscow, Russia.
3Department of Bioengineering and Medical Equipment and Systems, Moscow State Technical University, Moscow, Russia.
4Laboratory of Biostatistics and Evidence Based Medicine, Mental Health Research Center of Russian Academy of Medical Sciences, Moscow, Russia.
5Institute of Neurocience, Newcastle University Institute for Ageing, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, UK.
Objectives: Although people with amnestic mild
cognitive impairment (aMCI) benefit from cerebrolysin treatment, some
still develop dementia. The aim of the current study was to identify
most informative clinical assessment tests to predict the therapy
efficacy in aMCI subjects treated with cerebrolysin. Methods: We studied
patients with amnestic mild cognitive impairment (aMCI; n = 53) who had
regular neurocognitive and clinical psychiatric assessments and were
treated with cerebrolysin i.v. infusions 20 × 30 ml twice a year over
three years period. Data were analyzed using non-parametric statistics,
cluster and linear discriminant analyses. Results: Combined mathematical
modeling enabled to predict cognitive decline from aMCI to dementia in
the cerebrolysin-treated patients based on their initial neurocognitive
assessment scores. We identified a “dementia risk group” with fast
cognitive decline (i.e. low efficacy of the treatment). Lower
baseline scores in the Mattis Dementia Rating Scale Memory subtest,
Mini-Mental State Examination (MMSE), 10 word list immediate recall, and
Frontal Assessment Battery tests when accompanied by higher depression
score (Hamilton Depression Rating Scale) suggest poor prognosis for aMCI
patients treated with cerebrolysin. Changes in scores on the MMSE,
Boston naming test, Digit span forward, and Wechsler scale subtest
“Categorical associations” during the treatment course are more
characteristic for patients who convert to dementia than their initial
scores. Conclusions: aMCI subjects treated with cerebrolysin with lower
baseline cognitive functioning and subclinical depression have poor
prognosis in terms of converting to dementia. Changes in the MMSE,
Boston naming test, Digit span forward, and Wechsler scale subtest
“Categorical associations” scores during the treatment course are more
informative to identify patients who will develop dementia than their
initial scores.
KEYWORDS
Cite this paper
Boksha, I. , Gavrilova, S. , Kolykhalov, I. ,
Fedorova, I. , Kalyn, I. , Selezneva, N. , Samorodov, A. , Miasoedov, S.
and Mukaetova-Ladinska, E. (2014) Progression of Cognitive Deficit
in Older People with Mild Cognitive Impairment Treated with
Cerebrolysin. Health, 6, 2581-2591. doi: 10.4236/health.2014.619297.
| [1] |
Petersen, R.C., Smith, G.E.,
Waring, S.C., Ivnik, R.J., Kokmen, E. and Tangelos, E.G. (1997) Aging,
Memory, and Mild Cognitive Impairment. International Psychogeriatrics,
9, 65-69. http://dx.doi.org/10.1017/S1041610297004717 |
| [2] |
Petersen, R.C., Smith, G.E.,
Waring, S.C., Ivnik, R.J., Tangalos, E.G. and Kokmen, E. (1999) Mild
Cognitive Impairment: Clinical Characterization and Outcome. Archives of
Neurology, 56, 303-308. http://dx.doi.org/10.1001/archneur.56.3.303 |
| [3] |
Petersen, R.C. (2004) Mild
Cognitive Impairment as a Diagnostic Entity. Journal of Internal
Medicine, 256, 183-194. http://dx.doi.org/10.1111/j.1365-2796.2004.01388.x |
| [4] |
Golob, E.J., Johnson, J.K. and
Starr, A. (2002) Auditory Event-Related Potentials during Target
Detection Are Abnormal in Mild Cognitive Impairment. Clinical
Neurophysiology, 113, 151-161. http://dx.doi.org/10.1016/S1388-2457(01)00713-1 |
| [5] |
Golob, E.J., Irimajiri, R. and
Starr, A. (2007) Auditory Cortical Activity in Amnestic Mild Cognitive
Impairment: Relationship to Subtype and Conversion to Dementia. Brain,
130, 740-752. http://dx.doi.org/10.0.4.69/brain/awl375 |
| [6] |
Schmidtke, K. and Hermeneit, S.
(2008) High Rate of Conversion to Alzheimer’s Disease in a Cohort of
Amnestic MCI Patients. International Psychogeriatrics, 20, 96-108. http://dx.doi.org/10.1017/S1041610207005509 |
| [7] | Gavrilova, S.I., Fedorova, I.B., Roshchina, I.F. and Korovaitseva, G.I. (2007) Prognosis of the Syndrome of Mild Cognitive Impairment: The Data of the Biennial Follow-Up Study. Zh Nevrol Psikhiatr Im S S Korsakova, 107, 4-10. |
| [8] | Vemuri, P., Wiste, H.J., Weigand, S.D., Knopman, D.S., Trojanowski, J.Q., et al. (2010) Serial MRI and CSF Biomarkers in Normal Aging, MCI, and AD. Neurology, 75, 143-151. http://dx.doi.org/10.1212/WNL.0b013e3181e7ca82 |
| [9] | Gavrilova, S.I., Kolykhalov, I.V., Fedorova, I.B., Selezneva, N.D., Kalyn, I.B., Roshchina, I.F., et al. (2010) Possibilities of Preventive Treatment of Alzheimer’s Disease: Results of the 3-Year Open Prospective Comparative Study on Efficacy and Safety of the Course Therapy with Cerebrolysin and Cavinton in Elderly Patients with the Syndrome of Mild Cognitive Impairment. Zh Nevrol Psikhiatr Im S S Korsakova, 110, 62-69. |
| [10] |
Gavrilova, S.I., Fedorova, Y.B.,
Roshchina, I.F. and Korovaitseva, G.I. (2008) Prognosis of Mild
Cognitive Impairment Syndrome: Data from a Two-Year Clinical Follow-Up
Study. Neuroscience and Behavioral Physiology, 38, 129-134. http://dx.doi.org/10.1007/s11055-008-0018-y |
| [11] | Korovaitseva, G.I., Shcherbatykh, T.V., Selezneva, N.V., Gavrilova, S.I., Golimbet, V.E., Voskresenskaia, N.I. and Rogaev, E.I. (2001) Genetic Association between the Apolipoprotein E (ApoE) Gene Alleles and Various Forms of Alzheimer’s Disease. Genetika, 37, 529-535. (Article in Russian) |
| [12] |
Caselli, R.J., Dueck, A.C.,
Osborne, D., Sabbagh, M.N., Connor, D.J., Ahern, G.L., et al. (2009)
Longitudinal Modeling of Age-Related Memory Decline and the APOE ε4
Effect. New England Journal of Medicine, 361, 255-263. http://dx.doi.org/10.1056/NEJMoa0809437 |
| [13] |
Petersen, R.C., Doody, R., Kurz,
A., Mohs, R.C., Morris, J.C., Rabins, P.V., et al. (2001) Current
Concepts in Mild Cognitive Impairment. JAMA Neurology, 58, 1985-1992. http://dx.doi.org/10.1001/archneur.58.12.1985 |
| [14] | Reisberg, B., Ferris, S.H., de Leon, M.J. and Crook, T. (1988) Global Deterioration Scale (GDS). Psychopharmacology Bulletin, 24, 661-663. |
| [15] |
Morris, J.C. (1993) The Clinical
Dementia Rating (CDR): Current Version and Scoring Rules. Neurology,
43, 2412. http://dx.doi.org/10.1212/WNL.43.11.2412-a |
| [16] |
Hamilton, M. (1960) A Rating
Scale for Depression. Journal of Neurology, Neurosurgery &
Psychiatry, 23, 56-62. http://dx.doi.org/10.1136/jnnp.23.1.56 |
| [17] | Hachinski, V.C. (1978) Cerebral Blood Flow Differentiation of Alzheimer’s Disease from Multi-Infarct Dementia. In: Katzman, R., Terry, R.D. and Bick, K.L., Eds., Alzheimer’s Disease: Senile Dementia and Related Disorder, Raven Press, New York, 97-104. |
| [18] |
Folstein, M.F., Folstein, S.E.
and McHugh, P.R. (1975) ‘Mini-Mental State’. A Practical Method for
Grading the Cognitive State of Patients for the Clinician. Journal of
Psychiatric Research, 12, 189-198. http://dx.doi.org/10.1016/0022-3956(75)90026-6 |
| [19] | Mattis, S. (1976) Mental Status Examination for Organic Mental Syndrome in the Elderly Patient. In: Bellack, L. and Karusu, T.B., Eds., Geriatric Psychiatry, Grune & Stratton, New York, 77-121. |
| [20] | Wechsler, D. (1981) Wechsler Adult Intelligence Scale-Revised. Psychological Corporation, New York. |
| [21] |
Collie, A., Myers, C.,
Schnirman, G., Wood, S. and Maruff, P. (2002) Selectively Impaired
Associative Learning in Older People with Cognitive Decline. Journal of
Cognitive Neuroscience, 14, 484-492. http://dx.doi.org/10.1162/089892902317361994 |
| [22] | Takayama, Y. (2010) A Delayed Recall Battery as a Sensitive Screening for Mild Cognitive Impairment: Follow-Up Study of Memory Clinic Patients after 10 Years. Journal of Medical and Dental Sciences, 57, 177-184. |
| [23] |
Dubois, B., Slachevsky, A.,
Litvan, I. and Pillon, B. (2000) The FAB: A Frontal Assessment Battery
at Bedside. Neurology, 55, 1621-1626. http://dx.doi.org/10.1212/WNL.55.11.1621 |
| [24] |
Brodaty, H., Gresham, M. and
Luscombe, G. (1997) The Prince Henry Hospital Dementia Caregivers’
Training Programme. International Journal of Geriatric Psychiatry, 12,
183-192. http://dx.doi.org/10.1002/(SICI)1099-1166(199702)12:2<183::AID-GPS584>3.0.CO;2-J |
| [25] |
Shulman, K.I., Shedletsky, R.
and Silver, I.L. (1986) The Challenge of Time: Clock-Drawing and
Cognitive Function in the Elderly. International Journal of Geriatric
Psychiatry, 1, 135-140. http://dx.doi.org/10.1002/gps.930010209 |
| [26] | Sunderland, T., Hill, J.L., Mellow, A.M., Lawlor, B.A., Gundersheimer, J., Newhouse, P.A. and Grafman, J.H. (1989) Clock Drawing in Alzheimer’s Disease: A Novel Measure of Dementia Severity. Journal of the American Geriatrics Society, 37, 725-729. |
| [27] | Kaplan, E.F., Goodglass, H. and Weintraub, S. (1983) The Boston Naming Test. 2nd Edition, Lea & Febiger, Philadelphia. |
| [28] | Sudakov, S.A. (2010) Cluster Analysis in Psychiatry and Clinical Psychology: A Guide. [In Russian] Medical Information Agency, Moscow. |
| [29] |
Morris, J.C., Storandt, M.,
Miller, J.P., McKeel, D.W., Price, J.L., Rubin, E.H. and Berg, L. (2001)
Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease.
JAMA Neurology, 58, 397-405. http://dx.doi.org/10.1001/archneur.58.3.397 |
| [30] |
Winblad, B., Palmer, K.,
Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L.O., et al. (2004)
Mild Cognitive Impairment-Beyond Controversies, towards a Consensus:
Report of the International Working Group on Mild Cognitive Impairment.
Journal of Internal Medicine, 256, 240-246. http://dx.doi.org/10.1111/j.1365-2796.2004.01380.x |
| [31] |
De Jager, C.A., Milwain, E. and
Budge, M. (2002) Early Detection of Isolated Memory Deficits in the
Elderly: The Need for More Sensitive Neuropsychological Tests.
Psychological Medicine, 32, 483-491. http://dx.doi.org/10.1017/S003329170200524X |
| [32] |
De Jager, C.A., Schrijnemaekers,
A.C., Honey, T.E. and Budge, M.M. (2009) Detection of MCI in the
Clinic: Evaluation of the Sensitivity and Specificity of a Computerized
Test Battery, the Hopkins Verbal Learning Test and the MMSE. Age and
Ageing, 38, 455-460. http://dx.doi.org/10.1093/ageing/afp068 |
| [33] |
Elias, M.F., Beiser, A., Wolf,
P.A., Au, R., White, R.F. and D’Agostino, R.B. (2000) The Preclinical
Phase of Alzheimer Disease: A 22-Year Prospective Study of the
Framingham Cohort. JAMA Neurology, 57, 808-813. http://dx.doi.org/10.1001/archneur.57.6.808 |
| [34] |
Schrijnemaekers, A.M., de Jager,
C.A., Hogervorst, E. and Budge, M.M. (2006) Cases with Mild Cognitive
Impairment and Alzheimer’s Disease Fail to Benefit from Repeated
Exposure to Episodic Memory Tests as Compared with Controls. Journal of
Clinical and Experimental Neuropsychology, 28, 438-455. http://dx.doi.org/10.1080/13803390590935462 |
| [35] |
De Jager, C.A. (2004) Changes
over Time in Memory, Processing Speed and Clock Drawing Tests Help to
Discriminate between Vascular Cognitive Impairment, Mild Cognitive
Impairment and Alzheimer’s Disease. Neurological Research, 26, 481-487. http://dx.doi.org/10.1179/016164104225016209 |
| [36] | Roses, A.D., Saunders, A.M., Corder, E.H., Pericak-Vance, M.A., Han, S.H., Einstein, G., et al. (1995) Influence of the Susceptibility Genes Apolipoprotein E-Epsilon 4 and Apolipoprotein E-Epsilon 2 on the Rate of Disease Expressivity of Late-Onset Alzheimer’s Disease. Arzneimittel-Forschung, 45, 413-417. |
| [37] |
Narasimhalu, K., Ang, S., De
Silva, D.A., Wong, M.C., Chang, H.M., Chia, K.S., et al. (2009) Severity
of CIND and MCI Predict Incidence of Dementia in an Ischemic Stroke
Cohort. Neurology, 73, 1866-1872. http://dx.doi.org/10.1212/WNL.0b013e3181c3fcb7 |
| [38] | Alvarez, X.A., Lombardi, V.R., Corzo, L., Pérez, P., Pichel, V., Laredo, M., et al. (2000) Oral Cerebrolysin Enhances Brain Alpha Activity and Improves Cognitive Performance in Elderly Control Subjects. Journal of Neural Transmission. Supplementum, 59, 315-328. |
| [39] |
Alvarez, X.A., Cacabelos, R.,
Laredo, M., Couceiro, V., Sampedro, C., Varela, M., et al. (2006) A
24-Week, Double-Blind, Placebo-Controlled Study of Three Dosages of
Cerebrolysin in Patients with Mild to Moderate Alzheimer’s Disease.
European Journal of Neurology, 13, 43-54. http://dx.doi.org/10.1111/j.1468-1331.2006.01222.x |
| [40] |
Chen, N., Yang, M., Guo, J.,
Zhou, M., Zhu, C. and He, L. (2013) Cerebrolysin for Vascular Dementia.
Cochrane Database of Systematic Reviews, 1, CD008900. http://dx.doi.org/10.1002/14651858.CD008900 |
| [41] | Damulin, I.V., Koberskaia, N.N. and Mkhitarian, E.A. (2007) The Effect of Cerebrolysin on Moderate Cognitive Impairment in Cerebral Vascular Insufficiency (a Clinical and Electrophysiological Study). Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova, 107, 32-38. (Article in Russian) eww141110lx |
评论
发表评论